No but, IMO, it's likely to be another of the large long-term holders taking something off the table, for whatever reason, it's their's to make the call. Just my gut feeling.B22.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago